| Date | Title | Description |
| 08.03.2024 | Mithra reports full year 2023 financial results | - |
| 05.03.2024 | Mithra announces changes to its executive management | - |
| 05.03.2024 | Mithra initiates monetization process, receives bridge loan from existing lenders | - |
| 30.11.2023 | Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States | Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States DONESTA® for the treatment of vasomotor symptoms of menopause, is expected to target the entire accessible US market of nearly 63... |
| 26.10.2023 | Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada | Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada Mithra to receive EUR 1.5 million milestone payout as a result of the signing of the agreement Additional licensing payout of EUR 15.55 million in regulatory and sal... |
| 03.08.2023 | Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement | - |
| 02.08.2022 | NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent | ADELAIDE, Australia, Aug. 2, 2022 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are pleased to announce NEXTSTELLIS® (drospirenone and estetrol tablets) has been nominated fo... |
| 07.02.2022 | Mithra Pharmaceuticals S A : Obtains Equity Funding for up to EUR 100 Million | Liege, Belgium, 7 February 2022 - 07:30 CET - Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the "Company" or "Mithra"), a company dedicated to women's health, today announces that it has entered into an equity fi... |
| 14.01.2022 | Mithra Pharmaceuticals S A : Announces Positive Top-Line Results from Donesta® Phase 3 Studies in Menopausal Women | Liege, Belgium, 14 January 2022 - 07:30 CET - Mithra (Euronext Brussels: MITRA), a company
dedicated to Women's Health, today announces positive efficacy top-line results from Donesta® Phase
3 pivotal "E4 Comfort" clinical trials ... |
| 10.01.2022 | Mithra Pharmaceuticals S A : Publication of a Transparency Notification Received from François Fornieri | Liege, Belgium, 10 January 2022 - 7:30 CET - Mithra (Euronext Brussels: MITRA), a company
dedicated to Women's Health today announces, in accordance with Article 14 of the Belgian Law of
2 May 2007 regarding the publication of major shareho... |
| 20.12.2021 | Mithra Pharmaceuticals S A : Issues a Put Option Notice Under Capital Agreement with LDA Capital | Liege, Belgium, 20 December 2021 - 17:45 CET - Mithra (Euronext Brussels: MITRA), a company
dedicated to Women's Health, today announces the issuance of a put option notice, according to the
terms of the capital commitment agreement signed ... |
| 30.11.2021 | Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS® Oral Contraceptive | ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce the Therapeutic Goods Administration (TGA) has approved the nove... |
| 29.11.2021 | Mithra Pharmaceuticals S A : holds today its Investor Day at CDMO | 29-11-2021 PRESS RELEASE
Mithra holds today its Investor Day at Mithra CDMO
Mithra's R&D and manufacturing center welcomes investors and analysts to give a strategic update of its pipeline and a tour of its facilities
Extension of the D... |
| 10.11.2021 | Mithra organizes its Investor Day on November 29, 2021 | Liege, Belgium, 10 November 2021 - 7:30 CET - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that it will host an Investor Day on Monday, November 29, 2021 at 9:00 am CET.
The event will be broadca... |
| 21.10.2021 | Mithra Pharmaceuticals S A : Announces Estelle® Launch in Belgium | Liege, Belgium, 21 October 2021 - 7:30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, is very pleased to announce that its novel combined oral contraceptive Estelle® is now available in Belgium. The product... |
| 06.10.2021 | Mithra Pharmaceuticals S A : Provides FDA Update on Myring® | Liege, Belgium, 6 October 2021 - 17:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that its US commercial partner Mayne Pharma (ASX:MYX) has received a complete response letter (CRL) from... |
| 04.10.2021 | Mithra Pharmaceuticals S A : Announces the Appointment of its Representative to Mayne Pharma's Board of Directors | 04-10-2021 PRESS RELEASE
Mithra Announces the Appointment of its Representative to Mayne Pharma's Board of Directors
Liege, Belgium, 4 October 2021 - 17:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, is ... |
| 24.09.2021 | Mithra Pharmaceuticals S A : Announces 2021 Half Year Results | Liege, Belgium, 24 September 2021 - 7:30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces its financial results for the six-month period ending on 30 June 2021, prepared in accordance with IFR... |
| 24.09.2021 | Mithra Pharmaceuticals S A : Announces Topline Results for COVID-19 Phase II Study | Liege, Belgium, 24 September 2021 - 7:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health today announces topline results of the Coronesta Phase II study, which aimed to assess the safety and efficacy of estet... |
| 21.09.2021 | Mithra Pharmaceuticals S A : Announces an Update on PeriNesta® | Liege, Belgium, 21 September 2021 -17:50 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces an update on its Research & Development strategy regarding the PeriNesta® product candidate.
At in... |
| 21.09.2021 | Donesta® Phase III: Recruitment Completion of American Study and Additional Recruitment in the European Study | LIEGE (Belgium, 21 September 2021 - 17:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces the completion of recruitment of 1015 menopausal women in the "E4 Comfort" pivotal study1 o... |
| 17.09.2021 | Mithra Pharmaceuticals S A : to Host Webcast for Half Year Financial Results on 24 September 2021 | 17-09-2021 PRESS RELEASE
Regulated information
Mithra to Host Webcast for Half Year
Financial Results on 24 September 2021
Liege, Belgium, 17 September 2021 - 7:30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Hea... |
| 16.09.2021 | Mithra Pharmaceuticals S A : Announces Estelle® Approval in Russia | Liege, Belgium, 16 September 2021 - 7:30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, is pleased to announce that the Russian Medicines Agency (Roszdravnadzor) has approved the registration application fo... |
| 13.08.2021 | Mithra Pharmaceuticals S A : extends the pricing period for the put option announced on July 2, 2021 under the agreement with LDA Capital | 13-08-2021 PRESS RELEASE
Regulated information
Mithra extends the pricing period for the put option announced on
July 2, 2021 under the agreement with LDA Capital
Liege, Belgium, 13 August 2021 - 17:45 CEST - Mithra (Euronext Brussels: MITR... |
| 02.07.2021 | Mithra Pharmaceuticals S A : Issues a Put Option Notice Under Capital Agreement with LDA Capital | 02-07-2021 PRESS RELEASE
Regulated information
Mithra Issues a Put Option Notice
Under Capital Agreement with LDA Capital
Liege, Belgium, 02 July 2021 - 17:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, ... |
| 27.05.2021 | MAYNE PHARMA GROUP LIMITED
Mayne Pharma : 27/05/2021 Nextstellis® Receives FDA Marketing Exclusivity and Phase III Data Published | Joint Press Release
NEXTSTELLIS® RECEIVES FDA MARKETING EXCLUSIVITY AND PHASE III DATA PUBLISHED
27 May 2021, Adelaide, Australia and Liege, Belgium: Mayne Pharma Group Limited
(ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: M... |
| 27.05.2021 | MITHRA PHARMACEUTICALS S.A.
Mithra Pharmaceuticals S A : Nextstellis® Receives FDA Marketing Exclusivity and Phase III Data Published | Joint Press Release
NEXTSTELLIS® RECEIVES FDA MARKETING EXCLUSIVITY AND PHASE III DATA PUBLISHED
27 May 2021, 07:30 CEST - Adelaide, Australia and Liege, Belgium - Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Eurone... |
| 20.05.2021 | MITHRA PHARMACEUTICALS S.A.
Mithra Pharmaceuticals S A : Announces European Approval of Estelle® | Liege, Belgium, 20 May 2021 -18:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, is very pleased to announce that the European Commission has accepted the registration application for the novel combined or... |
| 28.04.2021 | MITHRA PHARMACEUTICALS S.A.
Mithra Pharmaceuticals S A : takes note of François Fornieri's indictment | 28-04-2021 PRESS RELEASE
Mithra takes note of François Fornieri's indictment
Liege, Belgium, 28 avril 2021 - 21:15 CEST - Mithra Pharmaceuticals SA (Euronext Brussels: MITRA), a company dedicated to Women's Health, announces having been inf... |
| 20.04.2021 | MITHRA PHARMACEUTICALS S.A.
Mithra Pharmaceuticals S A : Releases 2020 Annual Report and Invitation to its Securities holders' Meeting | Liege, Belgium, 20 April 2021 - 7:30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health today announces the publication of its 2020 Annual Report and the invitation to its ordinary and extraordinary general meet... |
| 16.04.2021 | MITHRA PHARMACEUTICALS S.A.
Mithra Pharmaceuticals S A : Publication of a Transparency Notification Received from Alychlo NV | 16-04-2021 PRESS RELEASE
Regulated information
Publication of a Transparency Notification
Received from Alychlo NV
Liege, Belgium, 16 April 2021 - 17:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today ... |
| 06.10.2020 | MITHRA PHARMACEUTICALS S.A.
Mithra Pharmaceuticals S A : Announces FDA update | Mithra's US partner Mayne Pharma receives complete response letter from FDA for Myring™ requesting additional data that is not normally requested for generic products
Based on the information available to date, Mithra expects to have the ne... |
| 18.06.2020 | MITHRA PHARMACEUTICALS S.A.
Mithra Pharmaceuticals S A : Successfully Raises EUR 65 Million By Means of a Private Placement via an Accelerated Bookbuild Offering | NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW.
18-06-2020
PRESS RELEASE
Insid... |
